Ibafloxacin

Chemical compound
  • QJ01MA96 (WHO)
Legal statusLegal status
  • CA: ℞-only
  • EU: Rx-only
Identifiers
  • 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
CAS Number
  • 91618-36-9 checkY
PubChem CID
  • 71186
ChemSpider
  • 64324 ☒N
UNII
  • 53VPK9R0T5
KEGG
  • D04485 checkY
CompTox Dashboard (EPA)
  • DTXSID8057853 Edit this at Wikidata
Chemical and physical dataFormulaC15H14FNO3Molar mass275.279 g·mol−13D model (JSmol)
  • Interactive image
  • Fc2cc1C(=O)/C(C(=O)O)=C\N3c1c(c2C)CCC3C
InChI
  • InChI=1S/C15H14FNO3/c1-7-3-4-9-8(2)12(16)5-10-13(9)17(7)6-11(14(10)18)15(19)20/h5-7H,3-4H2,1-2H3,(H,19,20) ☒N
  • Key:DXKRGNXUIRKXNR-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Ibafloxacin (INN) is a fluoroquinolone antibiotic[1] drug formally approved for use in the European Union for veterinary medicine.[2]

References

  1. ^ Horspool LJ, van Laar P, van den Bos R, Mawhinney I (June 2004). "Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles". Journal of Veterinary Pharmacology and Therapeutics. 27 (3): 147–53. doi:10.1111/j.1365-2885.2004.00561.x. PMID 15189300.
  2. ^ "EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) IBAFLIN" (PDF). European Medicines Agency. 1 September 2007.
  • v
  • t
  • e
Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor
Sulfonamides
(DHPS inhibitor)
Short-acting
Intermediate-acting
Long-acting
Other/ungrouped
Combinations
Other DHPS inhibitors
Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation
Fluoroquinolones
2nd generation
3rd generation
4th generation
Veterinary
Newer non-fluorinated
Related (DG)
Anaerobic DNA
inhibitors
Nitroimidazole derivatives
Nitrofuran derivatives
RNA synthesis
Rifamycins/
RNA polymerase
Lipiarmycins


Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e